Matisse Capital’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.96M | Sell |
26,077
-1,228
| -4% | -$275K | 2.55% | 4 |
|
|
2025
Q4 | $5.82M | Buy |
27,305
+1,285
| +5% | +$265K | 2.6% | 5 |
|
|
2025
Q3 | $5.17M | Sell |
26,020
-1,922
| -7% | -$358K | 2.33% | 5 |
|
|
2025
Q2 | $4.82M | Sell |
27,942
-1,732
| -6% | -$282K | 2.28% | 4 |
|
|
2025
Q1 | $4.62M | Sell |
29,674
-822
| -3% | -$117K | 2.44% | 4 |
|
|
2024
Q4 | $4.2M | Sell |
30,496
-3,188
| -9% | -$419K | 2.13% | 4 |
|
|
2024
Q3 | $5.03M | Sell |
33,684
-1,045
| -3% | -$141K | 2.45% | 4 |
|
|
2024
Q2 | $4.74M | Sell |
34,729
-811
| -2% | -$110K | 2.34% | 4 |
|
|
2024
Q1 | $5.37M | Buy |
35,540
+905
| +3% | +$129K | 2.58% | 5 |
|
|
2023
Q4 | $4.36M | Buy |
34,635
+8,380
| +32% | +$835K | 2.32% | 5 |
|
|
2023
Q3 | $2.46M | Sell |
26,255
-5,695
| -18% | -$533K | 1.74% | 6 |
|
|
2023
Q2 | $2.85M | Buy |
31,950
+3,800
| +13% | +$331K | 1.77% | 7 |
|
|
2023
Q1 | $3.02M | Sell |
28,150
-2,370
| -8% | -$271K | 1.95% | 5 |
|
|
2022
Q4 | $3.73M | Buy |
30,520
+5,110
| +20% | +$593K | 3.31% | 4 |
|
|
2022
Q3 | $2.62M | Hold |
25,410
| – | – | 3.33% | 4 |
|
|
2022
Q2 | $2.36M | Buy |
25,410
+600
| +2% | +$56.5K | 2.24% | 4 |
|
|
2022
Q1 | $2.91M | Buy |
24,810
+970
| +4% | +$112K | 2.68% | 5 |
|
|
2021
Q4 | $3.21M | Buy |
23,840
+3,930
| +20% | +$585K | 2.22% | 8 |
|
|
2021
Q3 | $3.17M | Buy |
19,910
+820
| +4% | +$112K | 1.17% | 25 |
|
|
2021
Q2 | $2.51M | Sell |
19,090
-1,100
| -5% | -$147K | 0.79% | 42 |
|
|
2021
Q1 | $2.6M | Buy |
20,190
+2,730
| +16% | +$415K | 0.75% | 46 |
|
|
2020
Q4 | $2.91M | Buy |
17,460
+1,300
| +8% | +$215K | 0.9% | 42 |
|
|
2020
Q3 | $2.49M | Buy |
16,160
+2,500
| +18% | +$359K | 1% | 39 |
|
|
2020
Q2 | $2.02M | Buy |
13,660
+1,500
| +12% | +$206K | 0.67% | 53 |
|
|
2020
Q1 | $1.37M | Buy |
12,160
+1,200
| +11% | +$156K | 0.54% | 56 |
|
|
2019
Q4 | $1.52M | Buy |
10,960
+430
| +4% | +$47.8K | 1.08% | 35 |
|
|
2019
Q3 | $1.01M | Buy |
10,530
+500
| +5% | +$55.8K | 1.25% | 26 |
|
|
2019
Q2 | $1.16M | Sell |
10,030
-100
| -1% | -$12K | 1.47% | 22 |
|
|
2019
Q1 | $1.19M | Buy |
10,130
+3,400
| +51% | +$298K | 1.44% | 25 |
|
|
2018
Q4 | $422K | Sell |
6,730
-4,600
| -41% | -$289K | 0.53% | 45 |
|
|
2018
Q3 | $803K | Sell |
11,330
-2,970
| -21% | -$204K | 0.72% | 45 |
|
|
2018
Q2 | $951K | Buy |
14,300
+5,200
| +57% | +$342K | 0.75% | 36 |
|
|
2018
Q1 | $595K | Sell |
9,100
-2,990
| -25% | -$168K | 0.36% | 71 |
|
|
2017
Q4 | $484K | Buy |
12,090
+3,500
| +41% | +$127K | 0.22% | 80 |
|
|
2017
Q3 | $311K | Hold |
8,590
| – | – | 0.15% | 92 |
|
|
2017
Q2 | $238K | Buy |
+8,590
| New | +$227K | 0.12% | 102 |
|
Other funds holding ASND
RCM
ACA
